Abstract
This article provides a succinct overview of the revisions and augmentations incorporated into the 2024 edition of GINA (Global Initiative for Asthma). A comparative analysis is conducted between the diagnostic and therapeutic algorithms for bronchial asthma (BA) in children outlined in the updated GINA guidelines and those delineated in the Kyrgyz clinical protocol on BA issued in 2023. Leveraging the latest iteration of GINA, a series of organizational, scientific, clinical, and diagnostic initiatives are slated for implementation in Kyrgyz Republic. Notably, on the basis of the department of allergology and clinical immunology of the National center for maternity and childhood care under the Ministry of health of the Kyrgyz Republic, a research laboratory on allergology, including a room for genetically engineered biological therapy, will be created.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
